PRESS RELEASES

Press Releases

19 03. 2019

LEO Pharma A/S and LTS Lohmann Therapie-Systeme AG initiate first-ever clinical trial of microarray patches for psoriasis treatment

2019-03-19T10:33:01+01:0019.03.2019|Kategorie(n): Press Releases|

LTS Lohmann Therapie-Systeme AG (LTS), a market leader in transdermal therapeutic systems, and LEO Pharma A/S, a global leader in dermatology, today announced that the companies will start the clinical trial of microarray patches for the local intradermal treatment of psoriasis.

Go to Top